Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-29 4:29 pm Sale | 2023-12-31 | 13G | EDESA BIOTECH INC EDSA | Velan Capital Investment Management LP | 63,492 1.970% | -190,476 (-75.00%) | Filing History |
| 2024-01-16 5:03 pm Sale | 2023-01-08 | 13D | EDESA BIOTECH INC EDSA | Pardeep Nijhawan Medicine Professional Corp | 630,012 19.300% | -24,973 (-3.81%) | Filing History |
| 2023-08-21 5:01 pm Purchase | 2023-08-04 | 13D | EDESA BIOTECH INC EDSA | Pardeep Nijhawan Medicine Professional Corp | 654,985 20.900% | 23,791 (+3.77%) | Filing History |
| 2023-01-13 5:28 pm Sale | 2023-01-10 | 13D | EDESA BIOTECH INC EDSA | Lumira Capital Investment Management Inc. | 249,853 9.000% | -36,228 (-12.66%) | Filing History |
| 2023-01-06 4:08 pm Purchase | 2022-12-23 | 13G | EDESA BIOTECH INC EDSA | Velan Capital Investment Management LP | 253,968 8.780% | 253,968 (New Position) | Filing History |
| 2022-11-08 12:18 pm Purchase | 2022-11-02 | 13D | EDESA BIOTECH INC EDSA | Pardeep Nijhawan Medicine Professional Corp | 631,194 22.100% | 214,383 (+51.43%) | Filing History |